HK Stock MarketDetailed Quotes

09995 REMEGEN

Watchlist
  • 30.500
  • +0.250+0.83%
Market Closed Apr 26 16:08 CST
16.60BMarket Cap-9797P/E (TTM)

REMEGEN Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
1,094.78%348.78M
--150.14M
--1.42B
Operating income
96.41%330.43M
40.16%1.08B
35.08%769.47M
20.15%419.07M
12.06%168.24M
-46.08%767.78M
397.47%569.64M
1,094.78%348.78M
150.14M
1.42B
Cost of sales
----
6.22%-253.14M
----
38.72%-102.66M
----
-301.92%-269.94M
----
-3,510.02%-167.51M
----
---67.16M
Operating expenses
-196.17%-74.36M
6.22%-253.14M
20.47%-177.8M
38.72%-102.66M
74.25%-25.11M
-301.92%-269.94M
-2,079.96%-223.57M
-3,510.02%-167.51M
-97.51M
-67.16M
Gross profit
78.91%256.08M
65.31%822.99M
70.97%591.67M
74.55%316.42M
171.98%143.13M
-63.31%497.84M
231.95%346.06M
638.33%181.27M
52.63M
1.36B
Selling expenses
-18.81%-187.5M
-75.90%-775.19M
-94.41%-539.79M
-133.51%-350.17M
-95.36%-157.82M
-67.59%-440.7M
-115.68%-277.66M
-146.27%-149.96M
---80.78M
-987.54%-262.97M
Administrative expenses
5.70%-74.26M
-15.09%-313.67M
-51.17%-242.87M
-57.70%-168.61M
-60.52%-78.75M
-23.97%-272.54M
-0.86%-160.66M
-8.42%-106.92M
---49.06M
-1.02%-219.84M
Research and development expenses
-32.62%-331.18M
-33.01%-1.31B
-29.50%-857.98M
-20.19%-540.45M
-14.46%-249.72M
-38.13%-982.08M
-26.29%-662.54M
-37.68%-449.67M
---218.17M
-52.63%-710.97M
Profit from asset sales
----
----
----
----
----
----
-3.02%15.5K
----
----
----
Revaluation surplus
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
----
----
----
-Changes in the fair value of other assets
-101.81%-49.46K
----
-55.15%5.17M
----
--2.73M
----
--11.53M
----
----
----
Impairment and provision
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-2,386.67%-5.6M
---1.47M
-627.66%-342K
-Other impairment is provision
-346.42%-4.66M
-1.33%-11.28M
-63.53%-14.92M
26.58%-4.11M
229.03%1.89M
-3,153.80%-11.13M
-1,814.98%-9.12M
-2,386.67%-5.6M
---1.47M
-627.66%-342K
Special items of operating profit
2.19%11.78M
-55.96%95.35M
32.59%35.44M
12.83%49.56M
55.95%11.53M
82.02%216.54M
43.26%26.73M
117.26%43.92M
--7.39M
204.44%118.96M
Operating profit
-1.58%-334.24M
-50.00%-1.49B
-40.94%-1.03B
-43.21%-697.37M
-13.06%-329.03M
-452.32%-992.07M
-5.41%-730.19M
-10.28%-486.95M
-291.02M
142.12%281.58M
Financing cost
-256.14%-10.71M
-241.73%-23.09M
-91.90%4.34M
-175.72%-6M
-17.79%6.86M
-26.94%-6.76M
128.81%53.61M
11.94%-2.18M
--8.34M
81.79%-5.32M
Share of profits of associates
----
---45K
----
----
----
----
----
----
----
----
Special items of earning before tax
-147.00%-3.97M
----
50.34%-5.78M
----
61.33%-1.61M
----
38.68%-11.64M
----
---4.16M
----
Earning before tax
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
139.59%276.26M
After-tax profit from continuing operations
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
139.59%276.26M
Earning after tax
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
139.59%276.26M
Profit attributable to shareholders
-7.77%-348.92M
-51.30%-1.51B
-49.75%-1.03B
-43.80%-703.36M
-12.88%-323.77M
-461.56%-998.83M
0.01%-688.22M
-10.15%-489.13M
-286.83M
139.59%276.26M
Basic earnings per share
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
-5.49%-0.96
-0.59
133.33%0.57
Diluted earnings per share
-8.33%-0.65
-48.94%-2.8
-44.70%-1.91
-35.42%-1.3
-1.69%-0.6
-429.82%-1.88
6.38%-1.32
-5.49%-0.96
-0.59
133.33%0.57
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
--
--
Ernst & Young
--
--
--
Ernst & Young
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover 96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M1,094.78%348.78M--150.14M--1.42B
Operating income 96.41%330.43M40.16%1.08B35.08%769.47M20.15%419.07M12.06%168.24M-46.08%767.78M397.47%569.64M1,094.78%348.78M150.14M1.42B
Cost of sales ----6.22%-253.14M----38.72%-102.66M-----301.92%-269.94M-----3,510.02%-167.51M-------67.16M
Operating expenses -196.17%-74.36M6.22%-253.14M20.47%-177.8M38.72%-102.66M74.25%-25.11M-301.92%-269.94M-2,079.96%-223.57M-3,510.02%-167.51M-97.51M-67.16M
Gross profit 78.91%256.08M65.31%822.99M70.97%591.67M74.55%316.42M171.98%143.13M-63.31%497.84M231.95%346.06M638.33%181.27M52.63M1.36B
Selling expenses -18.81%-187.5M-75.90%-775.19M-94.41%-539.79M-133.51%-350.17M-95.36%-157.82M-67.59%-440.7M-115.68%-277.66M-146.27%-149.96M---80.78M-987.54%-262.97M
Administrative expenses 5.70%-74.26M-15.09%-313.67M-51.17%-242.87M-57.70%-168.61M-60.52%-78.75M-23.97%-272.54M-0.86%-160.66M-8.42%-106.92M---49.06M-1.02%-219.84M
Research and development expenses -32.62%-331.18M-33.01%-1.31B-29.50%-857.98M-20.19%-540.45M-14.46%-249.72M-38.13%-982.08M-26.29%-662.54M-37.68%-449.67M---218.17M-52.63%-710.97M
Profit from asset sales -------------------------3.02%15.5K------------
Revaluation surplus -101.81%-49.46K-----55.15%5.17M------2.73M------11.53M------------
-Changes in the fair value of other assets -101.81%-49.46K-----55.15%5.17M------2.73M------11.53M------------
Impairment and provision -346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M-2,386.67%-5.6M---1.47M-627.66%-342K
-Other impairment is provision -346.42%-4.66M-1.33%-11.28M-63.53%-14.92M26.58%-4.11M229.03%1.89M-3,153.80%-11.13M-1,814.98%-9.12M-2,386.67%-5.6M---1.47M-627.66%-342K
Special items of operating profit 2.19%11.78M-55.96%95.35M32.59%35.44M12.83%49.56M55.95%11.53M82.02%216.54M43.26%26.73M117.26%43.92M--7.39M204.44%118.96M
Operating profit -1.58%-334.24M-50.00%-1.49B-40.94%-1.03B-43.21%-697.37M-13.06%-329.03M-452.32%-992.07M-5.41%-730.19M-10.28%-486.95M-291.02M142.12%281.58M
Financing cost -256.14%-10.71M-241.73%-23.09M-91.90%4.34M-175.72%-6M-17.79%6.86M-26.94%-6.76M128.81%53.61M11.94%-2.18M--8.34M81.79%-5.32M
Share of profits of associates -------45K--------------------------------
Special items of earning before tax -147.00%-3.97M----50.34%-5.78M----61.33%-1.61M----38.68%-11.64M-------4.16M----
Earning before tax -7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M139.59%276.26M
After-tax profit from continuing operations -7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M139.59%276.26M
Earning after tax -7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M139.59%276.26M
Profit attributable to shareholders -7.77%-348.92M-51.30%-1.51B-49.75%-1.03B-43.80%-703.36M-12.88%-323.77M-461.56%-998.83M0.01%-688.22M-10.15%-489.13M-286.83M139.59%276.26M
Basic earnings per share -8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32-5.49%-0.96-0.59133.33%0.57
Diluted earnings per share -8.33%-0.65-48.94%-2.8-44.70%-1.91-35.42%-1.3-1.69%-0.6-429.82%-1.886.38%-1.32-5.49%-0.96-0.59133.33%0.57
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young------Ernst & Young------Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg